HAEGARDA C1 Esterase Inhibitor Subcutaneous (Human) is a Kit in the Plasma Derivative category. It is labeled and distributed by Csl Behring Gmbh. The primary component is .
Product ID | 63833-829_79516135-ba14-41c9-bb9a-6938cfd297ff |
NDC | 63833-829 |
Product Type | Plasma Derivative |
Proprietary Name | HAEGARDA C1 Esterase Inhibitor Subcutaneous (Human) |
Generic Name | Human C1-esterase Inhibitor |
Dosage Form | Kit |
Marketing Start Date | 2017-06-22 |
Marketing Category | BLA / BLA |
Application Number | BLA125606 |
Labeler Name | CSL Behring GmbH |
Active Ingredient Strength | 0 |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 2017-06-22 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | BLA |
Application Number | BLA125606 |
Product Type | PLASMA DERIVATIVE |
Billing Unit | EA |
Marketing Start Date | 2017-06-22 |
NDC | Brand Name | Generic Name |
---|---|---|
63833-825 | Berinert | HUMAN C1-ESTERASE INHIBITOR |
42227-081 | Cinryze | HUMAN C1-ESTERASE INHIBITOR |
42227-083 | Cinryze | HUMAN C1-ESTERASE INHIBITOR |
63833-828 | HAEGARDA | HUMAN C1-ESTERASE INHIBITOR |
63833-829 | HAEGARDA | HUMAN C1-ESTERASE INHIBITOR |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
HAEGARDA 86867299 5158875 Live/Registered |
CSL Behring GmbH 2016-01-06 |